Ip C - Search Results

1

New concepts in selenium chemoprevention.

Ip C, Dong Y, Ganther HE. Ip C, et al. Cancer Metastasis Rev. 2002;21(3-4):281-9. doi: 10.1023/a:1021263027659. Cancer Metastasis Rev. 2002. PMID: 12549766 Review.

2

Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays.

Dong Y, Ganther HE, Stewart C, Ip C. Dong Y, et al. Among authors: ip c. Cancer Res. 2002 Feb 1;62(3):708-14. Cancer Res. 2002. PMID: 11830524

3

Evidence of a field effect associated with mammary cancer chemoprevention by methylseleninic acid.

Dong Y, Ip C, Ganther H. Dong Y, et al. Among authors: ip c. Anticancer Res. 2002 Jan-Feb;22(1A):27-32. Anticancer Res. 2002. PMID: 12017302

4

Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array.

Dong Y, Zhang H, Hawthorn L, Ganther HE, Ip C. Dong Y, et al. Among authors: ip c. Cancer Res. 2003 Jan 1;63(1):52-9. Cancer Res. 2003. PMID: 12517777

5

Cell cycle arrest biomarkers in human lung cancer cells after treatment with selenium in culture.

Swede H, Dong Y, Reid M, Marshall J, Ip C. Swede H, et al. Among authors: ip c. Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1248-52. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14652289

6

Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers.

Dong Y, Zhang H, Gao AC, Marshall JR, Ip C. Dong Y, et al. Among authors: ip c. Mol Cancer Ther. 2005 Jul;4(7):1047-55. doi: 10.1158/1535-7163.MCT-05-0124. Mol Cancer Ther. 2005. PMID: 16020662

7

Endoplasmic reticulum stress signal mediators are targets of selenium action.

Wu Y, Zhang H, Dong Y, Park YM, Ip C. Wu Y, et al. Among authors: ip c. Cancer Res. 2005 Oct 1;65(19):9073-9. doi: 10.1158/0008-5472.CAN-05-2016. Cancer Res. 2005. PMID: 16204082

8

Efficacy of trimethylselenonium versus selenite in cancer chemoprevention and its modulation by arsenite.

Ip C, Ganther H. Ip C, et al. Carcinogenesis. 1988 Aug;9(8):1481-4. doi: 10.1093/carcin/9.8.1481. Carcinogenesis. 1988. PMID: 3402045

9

Cancer chemoprevention by aliphatic selenocyanates: effect of chain length on inhibition of mammary tumors and DMBA adducts.

Ip C, Vadhanavikit S, Ganther H. Ip C, et al. Carcinogenesis. 1995 Jan;16(1):35-8. Carcinogenesis. 1995. PMID: 7834803

10

Triphenylselenonium and diphenylselenide in cancer chemoprevention: comparative studies of anticarcinogenic efficacy, tissue selenium levels and excretion profile.

Ip C, Lisk DJ, Ganther H, Thompson HJ. Ip C, et al. Anticancer Res. 1997 Sep-Oct;17(5A):3195-9. Anticancer Res. 1997. PMID: 9413148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

476 results

Search Page

Filters